Brogidirsen shows motor benefits and safety over 3.5 years of treatment in people with DMD who are amenable to exon 44 ...

Feeling discouraged by the progression of his FSHD, columnist Robin Stemple focuses on the love and kind gestures he's ...

Three boys with DMD given the gene therapy GNT0004 in a trial showed sustained improvements in motor function after two years ...

Columnist Betty Vertin's sons with Duchenne MD have seen their social circle shrink over the years, but they now enjoy time with each other.

Health Canada approved Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD) in patients ages 4 and older.

Columnist Shalom Lim and his girlfriend, Amanda, were among the disability advocates who let their voices be heard at a ...

Avidity's exon-skipping therapy del-zota led to functional gains for people with DMD, regardless of their walking abilities, ...

By grounding himself in the reasons why he keeps moving forward, columnist Patrick Moeschen is able to figure out how to ...

Mondays are usually a relaxing day for columnist Betty Vertin, but this one left her flat on her back after lifting her son into the shower.

For boys who start corticosteroids for DMD, being taller is tied with slower growth, and being older is tied to more weight ...

Satellos Bioscience is planning a Phase 2 trial in the U.S. to test SAT-3247 in children with Duchenne who are able to walk.

While I was driving, walking, and living independently in high school, he’d had the opposite experience. For Andrew, his high school days consisted of bone breaks, personal care assistants, hospital ...